slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
12,181-12,240 of 319,975
02
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Attention1 hit
03
The slide uses a funnel metaphor to represent data filtering/refinement.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
04
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
05
Includes a forward-looking statement box at the bottom.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · NeedLoop · Pattern Hunter1 hit
06
The slide uses a combination of a bar chart for M&A volume and a diverging bar chart for GDP growth to illustrate correlation.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · NeedLoop · Pattern Hunter1 hit
07
The chart displays annual transaction volumes with percentage breakdowns per country. A callout highlights the 2023 total for the 6 main countries.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Loop · Pattern Hunter1 hit
08
The slide uses a stacked bar chart to show sector composition by country, with a total aggregate bar on the right.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Loop · Pattern Hunter1 hit
09
The chart uses a Marimekko style to represent both the volume of transactions (width) and the percentage breakdown (height) per country.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Loop · Pattern Hunter1 hit
10
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
11
Slide contains a list of specific M&A examples for Corporate, PE, and VC categories.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · SatisfactionLoop · Zoom In1 hit
12
The chart shows a significant drop in 2023 compared to previous years, with a -58% annotation.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · SatisfactionLoop · Zoom In1 hit
13
The chart shows a clear shift from corporate-dominated M&A to increased VC and PE participation over the decade.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · SatisfactionLoop · Zoom In1 hit
14
The slide uses a process-flow style to link acquirers to targets and their strategic context.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · SatisfactionLoop · Zoom In1 hit
15
The slide uses a clear visual structure to map acquirers to targets and provides bulleted summaries for each transaction.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · SatisfactionLoop · Zoom In1 hit
16
The slide uses a hub-and-spoke style layout to connect PE firms to their specific portfolio acquisitions.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · SatisfactionLoop · Zoom In1 hit
17
The slide highlights international VC activity in the Brazilian market.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
18
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
19
Slide 19 from an L.E.K. consulting deck.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
20
The chart shows a significant decline in 2023 compared to previous years.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
21
The slide uses a stacked bar chart to show the composition of M&A deals in Mexico over a decade, accompanied by a table of CAGR metrics and a list of qualitative highlights.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
22
The slide uses a process-flow style to show acquirer-target relationships.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
23
The slide uses a case study format to highlight market activity.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
24
Includes a footer with additional relevant deals and source attribution.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
25
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
26
Slide 26 of an L.E.K. deck.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
27
The chart highlights a shift in sector focus for M&A activity in Colombia over a decade.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
28
The chart shows a clear decline in total deal volume over the decade, with a shift in investor composition.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
29
The chart shows a clear peak in deal volume in 2018 followed by a decline, with a specific callout for a 30% drop between 2021 and 2023.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
30
The chart highlights the dominance of the Oil, Gas, Energy, and Mining sector, while TMT's share increases over time. A callout indicates a -24% change between 2021 and 2022.Mergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting Beat · Action1 hit
31
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
32
Mergers and Acquisitions in LatAm: Evolution and prospectsMergers and Acquisitions in LatAm: Evolution and prospects · L.E.K.
Consulting deck Strategy consulting 1 hit
01
Perspectives on US Healthcare Inflation Insights from L.E.K. ConsultingPerspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Situation & Context1 hit
02
Perspectives on US Healthcare Inflation Insights from L.E.K. ConsultingPerspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
The chart uses a dual-line plot to show the divergence between healthcare and general inflation, with a shaded region for the Great Recession.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
04
Data shows hospital-related services as the primary driver of recent healthcare inflation.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
05
The chart uses a grouped bar structure to compare annual inflation trends across 12 specific healthcare sub-segments.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Mece Breakdown1 hit
06
The slide uses a dual-axis chart combining line graphs for cumulative change and bar charts for 12-month percentage change.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Evidence & Proof1 hit
07
The slide uses a side-by-side comparison framework to contrast opposing economic forces.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
08
The chart highlights a divergence between healthcare inflation and general inflation, with a specific forecast range for healthcare.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
09
The slide uses a vertical arrow to indicate a progression from 'Nearer-term/Lower potential impact' to 'Longer-term/Greater potential impact'.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
10
The slide uses a vertical arrow to indicate a progression from 'Nearer-term/Lower potential impact' to 'Longer-term/Greater potential impact'.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
11
The slide uses a vertical arrow to indicate a progression from 'Nearer-term/Lower potential impact' to 'Longer-term/Greater potential impact'.Perspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
12
Perspectives on US Healthcare Inflation Insights from L.E.K. ConsultingPerspectives on US Healthcare Inflation Insights from L.E.K. Consulting · L.E.K. Consulting
Consulting deck Strategy consulting 1 hit
01
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
02
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
05
The table is segmented into three thematic blocks: demographics, economic indicators, and healthcare market metrics.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
06
Uses a PEST framework (Policy, Economy, Society, Technology) to structure the market analysis.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
07
The slide uses a comparative bar chart structure to contrast high growth in China (29% CAGR) against stable growth in the U.S. (3% CAGR).Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
08
The slide uses a honeycomb layout to group regulatory initiatives. Color coding indicates the nature of the policy (R&D, Registration, Pricing/Market Access, Commercialization).Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
09
The slide uses stacked bar charts to show the composition of clinical trials by phase (I, II, III) for China and the US.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
10
Data refers to enterprises above designated annual revenue size (>20M RMB). Exchange rate 6.25 used.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & Complication1 hit
11
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
12
The slide combines quantitative survey data (N=101) with qualitative expert quotes to contextualize the market sentiment.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
13
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
14
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
15
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development ReportPivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
16
The chart uses a broken y-axis to accommodate the large number of companies in the 1-5 project range.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
17
The chart displays 4 categories of FDA designations with stacked segments representing product types.Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · L.E.K.
Consulting deck Strategy consulting Beat · Solution & ApproachLoop · Cost Of Inaction1 hit